Advertisement
Singapore markets open in 9 hours
  • Straits Times Index

    3,338.57
    +5.77 (+0.17%)
     
  • S&P 500

    5,463.74
    +3.26 (+0.06%)
     
  • Dow

    39,153.00
    +34.14 (+0.09%)
     
  • Nasdaq

    17,808.37
    +75.76 (+0.43%)
     
  • Bitcoin USD

    62,954.14
    +1,349.76 (+2.19%)
     
  • CMC Crypto 200

    1,304.97
    +2.90 (+0.22%)
     
  • FTSE 100

    8,166.76
    +2.64 (+0.03%)
     
  • Gold

    2,338.00
    -1.60 (-0.07%)
     
  • Crude Oil

    82.85
    +1.31 (+1.61%)
     
  • 10-Yr Bond

    4.4770
    +0.1340 (+3.09%)
     
  • Nikkei

    39,631.06
    +47.98 (+0.12%)
     
  • Hang Seng

    17,718.61
    +2.11 (+0.01%)
     
  • FTSE Bursa Malaysia

    1,598.20
    +8.11 (+0.51%)
     
  • Jakarta Composite Index

    7,139.63
    +76.05 (+1.08%)
     
  • PSE Index

    6,398.77
    -13.14 (-0.20%)
     

Accrelist launches ninth medical aesthetics clinic at Clarke Quay

This is the company’s third location in the central region after Raffles City and Orchard Central.

Accrelist has launched its ninth medical aesthetics clinic at Clarke Quay — the company’s third location in the central region after Raffles City and Orchard Central.

Accrelist Medical Aesthetics group of companies (A.M Aesthetics) first acquired a chain of four local clinics in October 2018. It grew into a network of clinics across Singapore, with plans for further expansion under the leadership of executive chairman and managing director Dr Terence Tea.

In FY2022 ended March, Accrelist’s revenue for its medical aesthetics services segment increased by 71.4% to $10.8 million due to the expansion of existing clinics and the opening of new clinics, as well as enhanced marketing.

ADVERTISEMENT

The company aims to broaden its revenue stream through its skincare products business A.M Skincare — its wholly owned subsidiary which complements its expanding clinic network.

Accrelist remains confident in the long-term prospects of its medical aesthetics business and will explore potential opportunities for long-term growth both in Singapore and overseas.

Shares in Accrelist closed 0.2 cents lower or -5% down on Oct 25 at 3.8 cents.

 

See Also: